Screener
iRadimed IRMD Finite Lived Intangible Assets - Gross
Finite Lived Intangible Assets - Gross at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Patents — fully amortized | 70 | 70 |
| Patents — in process | 74 | 74 |
| Internally developed software — in use | 3,950 | 3,934 |
| Internally developed software — in process | 424 | 374 |
| Trademarks | 44 | 44 |
| 5,005 | 4,939 | |
| Accumulated amortization | (1,719) | (1,555) |
| Total | $3,286 | $3,384 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's finite lived intangible assets - gross?
- iRadimed (IRMD) reported finite lived intangible assets - gross of $5.01M in Q1 2026.
- What does finite lived intangible assets - gross mean?
- This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.
Ask your AI about iRadimed's finite lived intangible assets - gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude